Clindamycin Capsules Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules
Available Strengths: 75 mg, 150 mg, 300 mg
Reference Brands: Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU)
Category:
Antibiotics
Clindamycin binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis and leading to cell death. It effectively treats skin, respiratory, and bone infections. Benefits include broad-spectrum activity, rapid bacterial eradication, and oral convenience, making it a reliable choice for severe bacterial infections when used appropriately.
Clindamycin Capsules is available in Oral Capsules
and strengths such as 75 mg, 150 mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clindamycin Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clindamycin Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clindamycin capsules are widely used antibiotics available in the US and EU, with regulatory approval from agencies like the FDA and EMA. These capsules are included in approved drug dossiers that ensure quality, safety, and efficacy. In the US, brands like Cleocin are FDA-approved, while in the EU, Dalacin C is commonly used. Both regions require rigorous clinical and compliance standards for marketing. For detailed information on regulatory requirements and approved dossiers, visit Pharmatradz. Stay updated on the latest regulations and licensing processes for clindamycin capsules across markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing